[
    [
        {
            "time": "2021-05-19",
            "original_text": "医药生物行业研究周报：建议以中期维度看医药行情",
            "features": {
                "keywords": [
                    "医药",
                    "生物",
                    "中期",
                    "行情"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业研究周报：建议以中期维度看医药行情",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "医药股再成机构热点 “成长猎手”杨栋时隔3个月“跨界”调研口腔赛道",
            "features": {
                "keywords": [
                    "医药股",
                    "机构热点",
                    "成长猎手",
                    "口腔赛道"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "口腔"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药股再成机构热点 “成长猎手”杨栋时隔3个月“跨界”调研口腔赛道",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "42.6亿并购全球前四原材料公司，迈瑞猛攻IVD“最肥”板块，外资垄断格局或打破",
            "features": {
                "keywords": [
                    "迈瑞",
                    "并购",
                    "IVD",
                    "外资垄断"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械",
                    "IVD"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "42.6亿并购全球前四原材料公司，迈瑞猛攻IVD“最肥”板块，外资垄断格局或打破",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "市场首只医疗器械ETF（159883）连续回调，短期波动或提供更优配置机会",
            "features": {
                "keywords": [
                    "医疗器械ETF",
                    "回调",
                    "配置机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "市场首只医疗器械ETF（159883）连续回调，短期波动或提供更优配置机会",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "依托深圳医疗器械全产业链优势 迈瑞医疗自主创新助力国产替代",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "深圳",
                    "国产替代"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "依托深圳医疗器械全产业链优势 迈瑞医疗自主创新助力国产替代",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "迈瑞医疗(300760)：拟收购HYTEST完善免疫诊断原料布局 IVD国际龙头未来可期",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "收购",
                    "HYTEST",
                    "IVD",
                    "国际龙头"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械",
                    "IVD"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "迈瑞医疗(300760)：拟收购HYTEST完善免疫诊断原料布局 IVD国际龙头未来可期",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "迈瑞医疗：依托深圳人才优势 加强企业自主创新",
            "features": {
                "keywords": [
                    "迈瑞医疗",
                    "深圳",
                    "自主创新"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "迈瑞医疗：依托深圳人才优势 加强企业自主创新",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "和讯SGI指数子榜单之新医疗TOP 10发布！迈瑞医疗蝉联第一，圣湘生物成长潜力凸显",
            "features": {
                "keywords": [
                    "和讯SGI指数",
                    "迈瑞医疗",
                    "圣湘生物",
                    "成长潜力"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "和讯SGI指数子榜单之新医疗TOP 10发布！迈瑞医疗蝉联第一，圣湘生物成长潜力凸显",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "Wind医药：每日行业动态（2021-05-19）",
            "features": {
                "keywords": [
                    "Wind医药",
                    "每日动态"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Wind医药：每日行业动态（2021-05-19)",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 3,
                "Headline_Structure": 4,
                "Source_Recency": 2
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "安信证券给予迈瑞医疗买入-A评级：拟收购HyTest完善免疫诊断原料布局，IVD国际龙头未来可期，目标价488.86元",
            "features": {
                "keywords": [
                    "安信证券",
                    "迈瑞医疗",
                    "买入-A",
                    "HyTest",
                    "IVD",
                    "目标价"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械",
                    "IVD"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "安信证券给予迈瑞医疗买入-A评级：拟收购HyTest完善免疫诊断原料布局，IVD国际龙头未来可期，目标价488.86元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-19",
            "original_text": "【医药】政策扶持中医药出口，品牌中药有望受益――医药行业周报——看好",
            "features": {
                "keywords": [
                    "政策扶持",
                    "中医药",
                    "出口",
                    "品牌中药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "中医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】政策扶持中医药出口，品牌中药有望受益――医药行业周报——看好",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]